(Q62110987)

English

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

clinical trial

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

Treatment Protocol for Patients With Standard Risk Acute Myelogenous Leukemia and Its Variants: Induction Using High-Dose Cytarabine, Mitoxantrone and Ethyol; Consolidation With Cytarabine and Idarubicin and Maintenance With 13 Cis Retinoic Acid and Alpha Interferon (English)

0 references

medical condition

leukemia

0 references

sponsor

Rush University Medical Center

0 references

country

United States of America

0 references

start time

April 1998